arrow
B

Bruce A. Perkins

University of Toronto
H指数:70
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Impact of Kidney Function on Diabetic Ketoacidosis and Severe Hypoglycemia Among Adults With Type 1 Diabetes: Insights From the T1D Exchange Real-World Observation Study

肾功能对1型糖尿病成人患者糖尿病酮症酸中毒和严重低血糖的影响:来自T1D Exchange真实世界观察研究的研究启示

2026-08-110
PRE
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

达格列净在心血管风险患者(无论是否患有2型糖尿病)中的心血管-肾脏效应:一项随机、双盲、安慰剂对照试验的结果

2026-02-010
PRE
Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathy

在2型糖尿病伴周围神经病变患者的一项2a期研究中,抗毒蕈碱药物pirenzepine的局部应用增加了下肢神经纤维密度。

2025-12-050
OAAI
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients

钠-葡萄糖协同转运蛋白-2抑制剂在肾移植受者中的疗效、机制与安全性:一项随机、双盲、安慰剂对照试验

2025-12-010
PRE
The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database

2型糖尿病及其大血管和微血管并发症的发病率迅速上升,不成比例地影响了年轻年龄组:来自一个国际联合数据库十年的证据

2025-08-240
OAAI
Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study

预测钠葡萄糖共转运蛋白-2抑制剂治疗后糖尿病酮症酸中毒发生:一项国际队列研究

2025-07-300
PRE
Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium-Glucose Cotransporter Inhibitors

毛细血管酮体水平与使用钠-葡萄糖共转运蛋白抑制剂的1型糖尿病患者的未来酮症酸中毒风险

2025-04-230
PRE
Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends over Four Decades

1型糖尿病患者胰岛素泵使用和糖尿病酮症酸中毒风险: 40年来的长期趋势

2025-02-010
PRE
Glycolytic lactate in diabetic kidney disease
2024-06-106
OA